𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Extracting Clinical Trial Design Information from MEDLINE Abstracts

✍ Scribed by Kazuo Hara; Yuji Matsumoto

Publisher
Springer
Year
2007
Tongue
English
Weight
304 KB
Volume
25
Category
Article
ISSN
0288-3635

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The value of structured abstracts in inf
The value of structured abstracts in information retrieval from MEDLINE
✍ ANDREW BOOTH; ALAN J. O'ROURKE πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 879 KB

Objective: To determine whether information retrieval might be enhanced by making each component of a structured abstract a separately searchable field. Design: Parallel searches on records arranged so that each abstract could either be searched in its entirety or as a collection of structured fiel

ChemInform Abstract: Tyrosine Kinase Inh
ChemInform Abstract: Tyrosine Kinase Inhibitors: From Rational Design to Clinical Trials.
✍ Peter Traxler; Guido Bold; Elisabeth Buchdunger; Giorgio Caravatti; Pascal Furet πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons βš– 25 KB πŸ‘ 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v

Optimal clinical trial design using valu
Optimal clinical trial design using value of information methods with imperfect implementation
✍ Andrew R. Willan; Simon Eckermann πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 167 KB

## Abstract Traditional sample size calculations for randomized clinical trials are based on the tests of hypotheses and depend on somewhat arbitrarily chosen factors, such as type I and II errors rates and the smallest clinically important difference. In response to this, many authors have propose

Tyrosine kinase inhibitors: From rationa
Tyrosine kinase inhibitors: From rational design to clinical trials
✍ Peter Traxler; Guido Bold; Elisabeth Buchdunger; Giorgio Caravatti; Pascal Furet πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 315 KB

## Abstract Protein kinases play a crucial role in signal transduction as well as in cellular proliferation, differentiation, and various regulatory mechanisms. The inhibition of growth related kinases, especially tyrosine kinases, might provide new therapies for diseases such as cancer. The progre